In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method-Reference-Cited by-同舟云学术

In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method

Published:2002-08 Issue:4 Volume:43 Page:319-321
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Abb Jochen

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference18 articles.

1. In vitro activity of quinupristin-dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci;Auckenthaler;Clinical Microbiology Infection,2000

2. Optimizing testing of methicillin-resistant Staphylococcus species;Baker;Diagnostic Microbiology and Infectious Disease,1994

3. Use of the E test for methicillin sensitivity testing;Bignardi;Journal of Antimicrobial Chemotherapy,1993

4. In vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic against Gram-positive bacteria;Brumfitt;Journal of Antimicrobial Therapy,1992

5. In vitro activity of linezolid against staphylococci;Cuny;Clinical Microbiology Infection,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A risk assessment framework for multidrug-resistant Staphylococcus aureus using machine learning and mass spectrometry technology;Briefings in Bioinformatics;2023-09-22

2. Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators;Expert Review of Anti-infective Therapy;2021-09-11

3. Novel vancomycin–peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus;Infection and Drug Resistance;2018-10

4. Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options);Expert Review of Clinical Pharmacology;2017-03-15

5. Resistance to Linezolid;Antimicrobial Drug Resistance;2017